Navigation Links
Frost & Sullivan Global Heart Health Ingredients Excellence in Financial & Risk Management Award Conferred on Pronova BioPharma
Date:9/8/2009

an organisation that is highly efficient with its resources. To be cost-competitive, the recipient has made efforts to bring about improvements in manufacturing efficiencies by impressive growth in sales, increased margins, better return on assets (ROA), and effective debt-equity management, adding value for investors.

Frost & Sullivan Best Practices Awards recognise companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About Pronova BioPharma ASA

Pronova BioPharma is a global leader in the research, development and manufacture of marine-originated omega-3 derived pharmaceutical products. Pronova BioPharma's first commercialized product is branded as Omacor((R)) in a number of countries throughout Europe and Asia and as Lovaza((TM)) in the United States. The product is manufactured at the Company's plant in Sandefjord, Norway using a unique and complex process. An additional manufacturing plant is under construction in Kalundborg, Denmark and is expected to be operational in first quarter 2010.

Omacor/Lovaza is the first and only EU- and FDA-approved omega-3 derived prescription drug. The drug is prescribed as an adjunct to diet for the treatment of elevated levels of triglycerides in humans, a condition known as hypertriglyceridemia (HTG), a form of dyslipidemia (or disorder of lipid metabolism). Very high triglycerides have been linked to a number of cardiovascular diseases. Omacor is also approved in key European and certain Asian markets for the secondary prevention of post-myocardial infarction, or Post-MI
'/>"/>

SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Aging Population, Heightened Consumer Awareness Propel U.S. Bone and Joint Health Ingredients, Says Frost & Sullivan
2. Added Investment Into Healthcare By the Government Drives Growth in the European Hospital Information Systems Market, Notes Frost & Sullivan
3. U.S. Compression Therapy Market to Reach $1.16 Billion in 2015, Finds Frost & Sullivan
4. Frost & Sullivan Recognizes Carestream Health with the 2009 Latin American Computed Radiology Customer Value Leadership Award
5. Mennen Medical Receives Frost & Sullivan 2009 European Patient Monitoring Technology Leadership Award
6. Frost & Sullivan: Growing Healthcare Tourism in Malaysia
7. A Wound that Does Not Heal: Frost & Sullivan Reveals the Impact of Chronic Ulcers on the European Healthcare System
8. Frost & Sullivan: Malaysia Diagnostics and Devices Industry Outlook 2009
9. Frost & Sullivan: Medico Legal Implications Related to the Usage of Electronic Health Record
10. Smart Payment Strategies Enable Growth in Home Health Care and Disease Management Markets for Remote Patient Monitoring, Finds Frost & Sullivan
11. Frost & Sullivan: Outsourcing/Offshoring Environment Possesses Considerable Potential for Pharmacovigilance Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... proven it true: exercise is good for you. But ... exercise may have an added benefit for cancer patients ... model of melanoma, found that combining exercise with chemotherapy ... Libonati, an associate professor in the School of Nursing ... Nursing Research, was the senior author on the study, ...
(Date:9/18/2014)... Lambertville, NJ (PRWEB) September 18, 2014 ... consulting firm, announced today that President and co-founder ... Business Journal’s Innovation Award Winners for 2014, recognizing ... naming him as an emerging executive of the ... health care and life sciences that continue to ...
(Date:9/18/2014)... Ben Quirk, CEO of Quirk Healthcare ... Award by the Savannah Science Seminar in recognition for ... the nation and especially in Savannah. , “I am ... “The Savannah Science Seminar is an amazing program that ... have gone through the program,” he added. Eleventh graders ...
(Date:9/18/2014)... group of international scientists have developed a new method ... here . , The Wildlife Conservation Society (WCS)-led research, ... Diseases , describes the use of fecal samples from ... been exposed to the virus. This represents a new ... potentially change the way Ebola virus is studied and ...
(Date:9/18/2014)... The National Institutes of Health (NIH) recently awarded ... million grant to the Los Angeles Biomedical Research Institute ... of a vaccine to protect patients from the healthcare-related ... (MRSA). , The National Institute of Allergy ... grant to LA BioMed infectious disease specialists John E. ...
Breaking Medicine News(10 mins):Health News:Exercise boosts tumor-fighting ability of chemotherapy, Penn team finds 2Health News:TayganPoint Executive Receives Prestigious Award from Philadelphia Business Journal 2Health News:Quirk Awarded the Alex Ormond, Jr. Leadership Award by the Savannah Science Seminar 2Health News:Research yields a game changer for improving understanding of Ebola and great apes 2Health News:Research yields a game changer for improving understanding of Ebola and great apes 3Health News:LA BioMed receives NIH grant to study vaccine for hospital-acquired infections 2
... ... outcomes reporting to monitor the impact of expected health improvements as it translates toward ... , ... Jacksonville, FL (PRWEB) December 17, 2009 -- HealthScreen Disease Management, an independent health risk ...
... , BERKELEY, Calif., Dec. 17 If proposed ... in the employer-based insurance system. Approximately 18.4 million Californians and ... employer-based insurance for their health care coverage. , Both ... for employer-based insurance. While the vast majority of employees ...
... Gala Raises Significant Funds to Benefit of Children with Autism and ... and Zachary Levi Join Ben Stiller to Ring in the Holiday ... annual Teddy Bear Ball, The Help Group honored three remarkable individuals. ... the Help Humanitarian Award in recognition of his far-reaching ...
... , NORCROSS, Ga., Dec. 16 Immucor, Inc. (Nasdaq: ... systems to the blood transfusion industry, today announced that Paul ... a new independent director, effective January 1, 2010. , ... medicine for more than 30 years. He is a tenured ...
... ... embryonic stem cell lines lack genetic diversity, a finding that raises ... sectors of society benefit from stem cell advances, according to a ... of its kind, the U-M team analyzed 47 embryonic stem cell ...
... that increase susceptibility to disease , WEDNESDAY, Dec. 16 ... to leprosy have been identified by scientists in Singapore ... 10,000 DNA samples from leprosy patients and healthy people ... that the innate immune response plays in the development ...
Cached Medicine News:Health News:Baptist Health System Selects HealthScreen Disease Management for Employee Health Management Services 2Health News:How National Health Reform Proposals Would Affect Employer-Based Plans in California 2Health News:How National Health Reform Proposals Would Affect Employer-Based Plans in California 3Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 2Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 3Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 4Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 5Health News:Immucor Appoints New Board Director 2Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 2Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 3Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 4Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 5Health News:Leprosy Genes Identified 2
(Date:9/18/2014)... 18, 2014   MacPractice,s MacPractice MD MU ... EHR certification, which designates that the software is capable ... and Stage 2 Meaningful Use measures required to qualify ... (ARRA).  MacPractice MD MU version 5.0 was certified on ... Office of the National Coordinator-Authorized Certification Body (ONC-ACB) and ...
(Date:9/18/2014)... , Sept. 18, 2014 Research and ... "China PTCA Balloon Market Investment Report, 2014-2016" report ... a indispensable medical device in percutaneous coronary intervention (PCI), ... but also as a device for pre-/post-stent dilatations. Therefore, ... to that of PCI. As national economy ...
(Date:9/18/2014)... SAN FRANCISCO , Sept. 18, 2014   ... it has secured an initial seed round of funding. ... initial investments, was led by a series of individual ... the investors whom participated in the initial round are; ... Yampa Valley Medical Center Urologist Stacy Childs, Rapha Family ...
Breaking Medicine Technology:MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 2MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 3MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 4MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 5China PTCA Balloon Market Investment Report, 2014-2016 2China PTCA Balloon Market Investment Report, 2014-2016 3Fruit Street Health Secures First Round Of Seed Funding Led By Group Of Medical Industry And Technology Leaders 2Fruit Street Health Secures First Round Of Seed Funding Led By Group Of Medical Industry And Technology Leaders 3
... 2011 Reportlinker.com announces that a new market ... Analytical Tool - Antibodies and Peptides ... "Analytical Tool – Antibodies and Peptides ... the vast amount of strategic possibilities that have ...
... 9, 2011 Reportlinker.com announces that a new ... Cetuximab - Comprehensive patent search ... Eliminate unnecessary risk with the industry benchmark ... is a regularly updated, professional patent search performed ...
Cached Medicine Technology:Reportlinker Adds Analytical Tool - Antibodies and Peptides in Oncology 2Reportlinker Adds Analytical Tool - Antibodies and Peptides in Oncology 3Reportlinker Adds Cetuximab - Comprehensive patent search 2Reportlinker Adds Cetuximab - Comprehensive patent search 3Reportlinker Adds Cetuximab - Comprehensive patent search 4
Inquire...
... The new GUCCI DONNA eyewear collection ... house,incorporating, with a vintage yet contemporary feel, ... leader., The new GUCCI UOMO optical and ... is,presented in classic lines with cutting-edge design ...
Inquire...
... art software package designed to assist in the ... a lens manufacturer with years of experience in ... designed to help you run your lab the ... software dictates., ,Designed specifically for integrated retail and ...
Medicine Products: